MD Anderson and NanoString Technologies Announce Multi-Year Collaboration

The University of Texas MD Anderson Cancer Center and NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced a multi-year collaboration to accelerate the development and adoption of a new type of assay based on NanoString's nCounter Analysis System.
Source: M. D. Anderson Cancer Center - News Releases - Category: Cancer & Oncology Source Type: news